(Q40517295)

21 September 2017

title

A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin (English)

1 reference

21 September 2017

Dana N Levasseur

1

1 reference

21 September 2017

Thomas M Ryan

2

1 reference

21 September 2017

Michael P Reilly

3

1 reference

21 September 2017

Steven L McCune

4

1 reference

21 September 2017

Toshio Asakura

5

1 reference

21 September 2017

Tim M Townes

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

14 April 2004

1 reference

Journal of Biological Chemistry

21 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

26

1 reference

21 September 2017

page(s)

27518-27524

1 reference

A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Crystal structure of sickle-cell deoxyhemoglobin at 5 A resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Hb F Synthesis in Sickle Cell Anaemia: a Comparison of Saudi Arab Cases with those of African Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Levels of fetal hemoglobin necessary for treatment of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Human gamma- to beta-globin gene switching in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Recombinant human hemoglobins designed for gene therapy of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Efficient site directed in vitro mutagenesis using ampicillin selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Mouse model of human beta zero thalassemia: targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Kinetics and Mechanism of Deoxyhemoglobin S Gelation: A New Approach to Understanding Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

Electrostatic interactions in the assembly of haemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M402578200

21 January 2018

Identifiers

DOI

10.1074/JBC.M402578200

1 reference

21 September 2017

1 reference